Cargando…
Breast cancer is a promising target for vaccination using cancer-testis antigens known to elicit immune responses
INTRODUCTION: Cancer-testis antigens (CTAGs) are expressed solely in germ cells and in malignant tissues. They are targets of immune responses mediated by cytotoxic T cells in some cancers, and there is much interest in developing vaccines that induce these responses. The purpose of the present stud...
Autores principales: | Taylor, Mark, Bolton, Louise M, Johnson, Peter, Elliott, Tim, Murray, Nick |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206722/ https://www.ncbi.nlm.nih.gov/pubmed/17650306 http://dx.doi.org/10.1186/bcr1749 |
Ejemplares similares
-
Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
por: Ai, Huihan, et al.
Publicado: (2023) -
Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
por: Yousef, Sara, et al.
Publicado: (2015) -
Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
por: Bai, Rui, et al.
Publicado: (2022) -
Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer
por: REN, BIQIONG, et al.
Publicado: (2016) -
Cancer testis antigen XAGE-1 is a promising marker for the diagnosis and treatment of ovarian cancer
por: Jumaa, Maysaa Ghazi, et al.
Publicado: (2021)